Hormone replacement therapy post Women's Health Initiative study: where do we stand?

被引：8

作者：

Calleja-Agius, Jean ^{[1
]}

Brincat, Mark P. ^{[1
]}

机构：

[1] Mater Dei Hosp, Dept Obstet & Gynaecol, Msida, Malta

来源：

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY | 2008年 / 20卷 / 06期

关键词：

hormone replacement therapy; oestrogen; progesterone; Women's Health Initiative;

D O I：

10.1097/GCO.0b013e32830dfa5c

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Purpose of review The aim of this review is to look at all publications from the past 18 months, which deal with the impact of the Women's Health Initiative Trial on hormone replacement therapy. Recent findings There is a definite decline in the use of hormone replacement therapy among menopausal women. Summary More research needs to be done on the long-term effects of hormone replacement therapy, especially with regard to ultra-low dose hormone therapy.

引用

页码：513 / 518

页数：6

共 40 条

[1] Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial
Anderson, GL
Judd, HL
Kaunitz, AM
Barad, DH
Beresford, SAA
Pettinger, M
Liu, J
McNeeley, SG
Lopez, AM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1739 - 1748
[2] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
Anderson, GL
Limacher, M
Assaf, AR
Bassford, T
Beresford, SAA
Black, H
Bonds, D
Brunner, R
Brzyski, R
Caan, B
Chlebowski, R
Curb, D
Gass, M
Hays, J
Heiss, G
Hendrix, S
Howard, BV
Hsia, J
Hubbell, A
Jackson, R
Johnson, KC
Judd, H
Kotchen, JM
Kuller, L
LaCroix, AZ
Lane, D
Langer, RD
Lasser, N
Lewis, CE
Manson, J
Margolis, K
Ockene, J
O'Sullivan, MJ
Phillips, L
Prentice, RL
Ritenbaugh, C
Robbins, J
Rossouw, JE
Sarto, G
Stefanick, ML
Van Horn, L
Wactawski-Wende, J
Wallace, R
Wassertheil-Smoller, S
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
[3] Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
Avis, NE
Stellato, R
Crawford, S
Bromberger, J
Ganz, P
Cain, V
Kagawa-Singer, M
[J]. SOCIAL SCIENCE & MEDICINE, 2001, 52 (03) : 345 - 356
[4] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
Barrett-Connor, E
Grady, D
Sashegyi, A
Anderson, PW
Cox, DA
Hoszowski, K
Rautaharju, P
Harper, KD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 847 - 857
[5] Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0
[6] Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[7] Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research
Bishop, M. R.
Logan, B. R.
Gandham, S.
Bolwell, B. J.
Cahn, J-Y
Lazarus, H. M.
Litzow, M. R.
Marks, D. I.
Wiernik, P. H.
McCarthy, P. L.
Russell, J. A.
Miller, C. B.
Sierra, J.
Milone, G.
Keating, A.
Loberiza, F. R., Jr.
Giralt, S.
Horowitz, M. M.
Weisdorf, D. J.
[J]. BONE MARROW TRANSPLANTATION, 2008, 41 (07) : 635 - 642
[8] Available medical choices for the management of menopause
Castelo-Branco, C
Palacios, S
Calaf, J
Vázquez, F
Lanchares, JL
[J]. MATURITAS, 2005, 52 : S61 - S70
[9] Chaikittisilpa Sukanya, 2007, Journal of the Medical Association of Thailand, V90, P628
[10] Summary of meta-analyses of therapies for postmenopausal osteoporosis
Cranney, A
Guyatt, G
Griffith, L
Wells, G
Tugwell, P
Rosen, C
[J]. ENDOCRINE REVIEWS, 2002, 23 (04) : 570 - 578

← 1 2 3 4 →